NIFTY 50▲24,197.05
201.70 (0.84%)
SENSEX▲79,448.27
666.03 (0.85%)
NIFTY BANK▲52,140.00
924.75 (1.81%)
TATA MOTORS▲834.20
10.10 (1.23%)
SUZLON ENERGY▲67.30
0.98 (1.48%)
TATA STEEL▲152.41
5.46 (3.72%)
INDIAN RAILWAY FINANCE CORP▼151.60
-1.64 (-1.07%)
TATA POWER▲434.15
5.10 (1.19%)
RAIL VIKAS NIGAM▲450.70
4.50 (1.01%)
RELIANCE INDUSTRIES▲1,306.50
4.35 (0.33%)
VODAFONE IDEA▲8.15
0.27 (3.43%)
ZOMATO▼241.49
-3.59 (-1.46%)
RELIANCE POWER▼41.58
-0.45 (-1.07%)
INDIAN RENEWABLE ENERGY▼204.48
-0.90 (-0.44%)
ADANI POWER▲601.50
16.50 (2.82%)
YES BANK▲20.65
0.32 (1.57%)
STATE BANK OF INDIA▲850.25
20.40 (2.46%)
NHPC▼79.98
-3.32 (-3.99%)
HDFC BANK▲1,759.10
45.00 (2.63%)
OLA ELECTRIC MOBILITY LTD▼74.20
-6.64 (-8.21%)
JIO FIN SERVICES LTD▲321.90
2.05 (0.64%)
INDIAN OIL CORP▲140.78
1.85 (1.33%)
BHARAT ELECTRONICS▲285.70
1.55 (0.55%)
GTL INFRA▲2.21
0.10 (4.74%)
MRF▼1,19,509.25
-1367.50 (-1.13%)
ADANI PORT & SEZ▼1,331.05
-18.20 (-1.35%)
JAIPRAKASH POWER VENTURES▲17.95
0.07 (0.39%)
ITC▼480.60
-4.00 (-0.83%)
Jubilant Pharmova Share Price
JUBLPHARMA
₹1,235.00-₹17.50 (-1.4%) TodayLast updated on 05 Nov, 2024 | 15:22 IST
Jubilant Pharmova Share Price Chart
Please wait...
About Jubilant Pharmova
Jubilant Pharmova Financials
Market cap ₹19,839 Crs | Open ₹1,249.10 | Close ₹1,252.50 |
Circuit range ₹1,503.00 - ₹1,002.00 | Day range ₹1,226.75 - ₹1,254.85 | Year range ₹391.95 - ₹1,296.65 |
Volume 3,33,286 | Avg. traded ₹1,243.18 | Revenue (12m) ₹6,920 Crs |
Jubilant PharmovaJubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services, and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.
Jubilant Pharmova Key indicators
52 week high ₹1,296.65 | 52 week low ₹391.95 | P/E ratio 33.5 |
P/B ratio 2.97 | ROE 1.32% | ROCE 2.64% |
Dividend yield 0.42% | Debt/Equity ratio 0.15 | EPS 1.99 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 3 experts in the last 7 days
Jubilant Pharmova Fundamentals
Jubilant Pharmova Financial Ratios
Operating profit margin15.28% | Net profit margin4.03% |
ROE1.32% | ROA1.06% |
ROCE2.64% |
Learn more
Jubilant Pharmova Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹1,280.00 | ₹1,252.50 | -0.80% |
Fri, Nov 1 2024 | ₹1,235.00 | ₹1,262.60 | |
Thu, Oct 31 2024 | ₹1,139.95 | ₹1,211.75 | |
Wed, Oct 30 2024 | ₹1,092.90 | ₹1,132.05 | |
Tue, Oct 29 2024 | ₹1,098.70 | ₹1,108.50 | |
Mon, Oct 28 2024 | ₹1,045.05 | ₹1,096.40 | |
Fri, Oct 25 2024 | ₹1,113.90 | ₹1,058.35 | -4.49% |
Thu, Oct 24 2024 | ₹1,138.25 | ₹1,108.05 | -2.65% |
Events
Corporate actions
Dividend • ₹5/share
Ex date 10 Aug 2023
Dividend • ₹5/share
Ex date 11 Aug 2022
Dividend • ₹5/share
Ex date
Learn more
More